Ebola outbreak response reshapes clinical supply strategy, demanding resilient forecasting, flexible depots, and rapid coordination to keep trials running safely.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- Clinical Supply Chains For Decentralized Trials In Sub-Saharan Africa
- What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release
- Clinical Trial Supply Failures Start Before First Patient In
- Clinical Trial Supply Impact Of ICSR Processing Delays
- Achieving Forecasting And Inventory Agility In Modern Clinical Supply Chains
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- How The Iran Conflict Threatens Global Clinical Supply Chains
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Biosample Tracking: A Consenting Dilemma
Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.
-
Using Tech Enabled Solutions To Boost Productivity And Sustainability
How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
GxP Inventory Enhances Supply Chain For Global Specialty Biotech Firm
Discover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.
-
Transportation Solutions For Cell And Gene Therapy Supply Chains
Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
Building A Global Cell And Gene Supply Chain Serving Personalized Medicine
Clinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.
-
What Does 2025 Hold For Pharma?
Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
Finding An RTSM Software To Keep Up With A Small Biotech
Stop letting rigid RTSM builds stall your oncology trials. Learn how agile configuration and right-sized documentation keep Phase I studies on track during frequent protocol amendments.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.